CVS HEALTH CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.26 USD | -0.46% |
|
+2.66% | -27.43% |
| 16/05 | CVS Health Retail Division Launches Snacks Brand Well Market | MT |
| 14/05 | Transcript : CVS Health Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 07:20 AM |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 37TCr 30,74100Cr | Sales 2025 * | 39TCr 32,33100Cr | Capitalization | 7.22TCr 6,01600Cr |
|---|---|---|---|---|---|
| Net income 2024 * | 766.5Cr 64TCr | Net income 2025 * | 892Cr 74TCr | EV / Sales 2024 * | 0.33 x |
| Net Debt 2024 * | 4.88TCr 4,06800Cr | Net Debt 2025 * | 4.5TCr 3,75000Cr | EV / Sales 2025 * | 0.3 x |
| P/E ratio 2024 * |
9.92
x | P/E ratio 2025 * |
8.47
x | Employees | 2,59,500 |
| Yield 2024 * |
4.63% | Yield 2025 * |
4.58% | Free-Float | 70.67% |
More Fundamentals
* Assessed data
More news
Latest transcript on CVS Health Corporation
More recommendations
More press releases
More news
| 1 day | -0.20% | ||
| 1 week | +3.23% | ||
| Current month | -14.89% | ||
| 1 month | -16.00% | ||
| 3 months | -24.49% | ||
| 6 months | -16.25% | ||
| Current year | -27.02% |
1 week
55.20
57.73
1 month
53.7070.21
Current year
53.7083.25
1 year
53.7083.25
3 years
53.70111.25
5 years
52.04111.25
10 years
51.72113.65
| Managers | Title | Age | Since |
|---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 28/18/28 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 01/22/01 |
David Falkowski
CMP | Compliance Officer | - | 01/11/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 20/11/20 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 28/18/28 |
Mary Schapiro
BRD | Director/Board Member | 68 | 10/17/10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.92% | 17 M€ | +7.73% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/24/17 | 57.31 | -0.37% | 4 792 888 |
| 16/24/16 | 57.52 | +2.24% | 13,974,759 |
| 15/24/15 | 56.26 | +0.46% | 16,430,970 |
| 14/24/14 | 56 | -0.83% | 15,410,680 |
| 13/24/13 | 56.47 | +1.16% | 11,767,627 |
Delayed Quote Nyse, May 17, 2024 at 07:38 pm IST
More quotes
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:
- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);
- medical benefits management (25.8%);
- other (0.1%).
Calendar
31/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
57.52
USD
Average target price
71.37
USD
Spread / Average Target
+24.08%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -27.02% | 7.22TCr | |
| +18.50% | 8.45TCr | |
| +4.65% | 2.77TCr | |
| -7.42% | 1.8TCr | |
| -0.53% | 1.75TCr | |
| +3.48% | 1.58TCr | |
| +6.54% | 1.36TCr | |
| +5.72% | 1.33TCr | |
| +69.75% | 1.25TCr | |
| -1.09% | 1.24TCr |
- Stock Market
- Equities
- CVS Stock